Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

PREVENTION

How to eliminate gastric cancer-related death worldwide?

Nature Reviews Clinical Oncology volume 15, pages 407–408 (2018)Cite this article

Subjects

Helicobacter pylori eradication therapy is effective in preventing gastric cancer, even in patients with advanced pre-neoplastic lesions (gastric atrophy and/or intestinal metaplasia). We must now focus on how to accomplish the goal of eliminating gastric cancer-related death worldwide; strategies for screening and treatment of gastric neoplasia (primary prevention) and post-treatment surveillance (secondary prevention) are discussed herein.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Uemura, N. et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345, 784–789 (2001).

    Article  PubMed  CAS  Google Scholar 

  2. Ford, A. C. et al. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ 348, g3174 (2004).

    Article  CAS  Google Scholar 

  3. Yoon, S. B. et al. Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. Helicobacter 19, 243–248 (2014).

    Article  PubMed  Google Scholar 

  4. Sugano, K. et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 64, 1353–1367 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Choi, I. J. et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N. Engl. J. Med. 378, 1085–1095 (2018).

    Article  PubMed  CAS  Google Scholar 

  6. Lee, Y. C. et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut 62, 676–682 (2013).

    Article  PubMed  Google Scholar 

  7. Tsuda, M. et al. Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan. Helicobacter 22, e12415 (2017).

    Article  PubMed Central  Google Scholar 

  8. Vilaichone, R. K. et al. Extremely high prevalence of Helicobacter pylori infection in Bhutan. World J. Gastroenterol. 19, 2806–2810 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kuo, Y. T. et al. Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 2, 707–715 (2017).

    Article  PubMed  Google Scholar 

  10. Rugge, M. et al. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. Gut https://doi.org/10.1136/gutjnl-2017-314600 (2018).

Download references

Acknowledgements

The author acknowledges support from the US NIH National Institute of Diabetes and Digestive and Kidney Diseases (grant DK62813); the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (grant 16H05191); and from the Japan Society for the Promotion of Science (Core-to-Core Program).

Author information

Authors and Affiliations

  1. Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Hasama-machi, Yufu, Oita Prefecture, Japan

    Yoshio Yamaoka

  2. Department of Medicine, Baylor College of Medicine, Houston, TX, USA

    Yoshio Yamaoka

Authors
  1. Yoshio Yamaoka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshio Yamaoka.

Ethics declarations

Competing interests

The author declares no competing interests.

Additional information

Related links

GLOBOCAN 2012: http://globocan.iarc.fr/

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamaoka, Y. How to eliminate gastric cancer-related death worldwide?. Nat Rev Clin Oncol 15, 407–408 (2018). https://doi.org/10.1038/s41571-018-0029-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41571-018-0029-8

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer